Abstract
The severe doxorubicin (DOXO) side effect of cardiomyopathy limits it clinical application as an effective anticancer drug. Although Ca(2+) overload was postulated as one of the mechanisms for this toxicity, its role was, however, disputable in terms of the contractile dysfunction. In this work, the dynamics of the intracellular Ca(2+) signal were optically mapped in a Langendorff guinea pig heart. We found that DOXO treatment: (1) Delayed the activation of the Ca(2+) signal. With the reference time set at the peak of the action potential (AP), the time lag between the peak of the Ca(2+) signal and AP (Ca-AP-Lag) was significantly prolonged. (2) Slowed down the intracellular Ca(2+) releasing and sequestering process. Both the maximum rising (MRV) and falling (MFV) velocity of the Ca(2+) signal were decreased. (3) Shortened the duration of the Ca(2+) signal in one cycle of Ca(2+) oscillation. The duration of the Ca(2+) signal at 50% amplitude (CaD50) was significantly shortened. These results suggested a reduced level of intracellular Ca(2+) after DOXO treatment. Furthermore, we found that the effect of tachypacing was similar to that of DOXO, and, interestingly, DOXO exerted contradictory effects on the tachypaced hearts: it shortened the Ca-AP-Lag, accelerated the MRV and MFV, and prolonged the CaD50. We, therefore, concluded that DOXO had a different effect on intracellular Ca(2+). It caused Ca(2+) underload in hearts with sinus rhythm; this might relate to the contractile dysfunction in DOXO cardiomyopathy. It led to Ca(2+) overload in the tachypaced hearts, which might contribute to the Ca(2+)-overload-related toxicity.